| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2000-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e1551cba1d2a0686c7b61bea20dd859
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44c8d1e759714507ea402ec602c57d28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bfca062543301bf82a6876a36a1ff00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743d1e4d69b242c46d614c4613e63425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2010abc44ab347e3e32cc7c1eb4ba936
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45fea8004992cca437dc36e3f8dcb8e |
| publicationDate |
2001-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001224385-A |
| titleOfInvention |
Test method for therapeutic or prophylactic agent for hyperlipidemia |
| abstract |
(57) [Problem] To provide a novel method for testing the effect as a therapeutic or preventive agent for hyperlipidemia, and a polynucleotide and an antibody used in the method. SOLUTION: In a cell cultured in the presence or absence of a test substance, a cultured cell is represented by nucleotide numbers 47 to 1411 of SEQ ID NO: 1 or nucleotide numbers 78 to 1457 of SEQ ID NO: 3 in the sequence listing. The expression level of mRNA having the nucleotide sequence (where t in the sequence is replaced by u) is detected, and the amount of mRNA detected in cells cultured in the presence of the test substance is higher than in cells cultured in the absence of the test substance. A method for selecting a test substance that reduces the amount of mRNA expression performed. |
| priorityDate |
1999-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |